OPTIFLUX 180NRE DIALYZER FINISHED ASSY. 0500318E

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,health report with the FDA on 2017-08-10 for OPTIFLUX 180NRE DIALYZER FINISHED ASSY. 0500318E manufactured by Ogden Manufacturing Plant.

Event Text Entries

[82786336] The reported complaint was not confirmed as the complaint device was not available for manufacturer evaluation. As such, a definitive conclusion regarding the complaint incident cannot be reached without a physical examination of the complaint device. A records review was performed on the reported lot. An investigation of the device manufacturing records was conducted by the manufacturer. There was no indication of product non-acceptance or deviation during the manufacturing process which could be associated with the reported event. The review included a check of non-conformances, rework, labeling, process controls, and any other occurrence in production potentially related to the complaint. The lot passed all release criteria. Review of the batch production record (bpr) did not reveal a probable cause for the customer complaint.
Patient Sequence No: 1, Text Type: N, H10


[82786337] A nurse at the user facility reported that a blood leak occurred approximately 1 hour after the patent? S hemodialysis (hd) treatment was initiated. The leak was noted as being an internal blood leak from the dialyzer. A fresenius 2008t hd machine was in use during the event and generated a blood leak alarm. No damage was observed to the dialyzer or its packaging. The dialysate line was checked with a blood leak test strip and returned a positive result. The blood within the extracorporeal circuit was not returned to the patient. The patient was re-setup on a different 2008t hd machine, and then the hd therapy was continued and successfully completed with no further issues. The patient's estimated blood loss (ebl) was noted as being approximately 300 milliliters (ml). No patient adverse effects were experienced and no medical intervention was required as a result of this event. A fresenius bloodline was in use during the hd therapy. The dialyzer was not available to be returned to the manufacturer for analysis as it was discarded by the user facility.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1713747-2017-00260
MDR Report Key6786370
Report SourceCOMPANY REPRESENTATIVE,HEALTH
Date Received2017-08-10
Date of Report2017-09-06
Date of Event2017-07-14
Date Mfgr Received2017-09-06
Device Manufacturer Date2017-04-01
Date Added to Maude2017-08-10
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactTHOMAS C. JOHNSON
Manufacturer Street920 WINTER ST.
Manufacturer CityWALTHAM MA 02451
Manufacturer CountryUS
Manufacturer Postal02451
Manufacturer Phone7816999499
Manufacturer G1OGDEN MANUFACTURING PLANT
Manufacturer Street475 WEST 13TH STREET
Manufacturer CityOGDEN UT 84404
Manufacturer CountryUS
Manufacturer Postal Code84404
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameOPTIFLUX 180NRE DIALYZER FINISHED ASSY.
Generic NameDIALYZER, CAPILLARY, HOLLOW FIBER
Product CodeFJI
Date Received2017-08-10
Catalog Number0500318E
Lot Number17DU03001
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeMO
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerOGDEN MANUFACTURING PLANT
Manufacturer Address475 WEST 13TH STREET OGDEN UT 84404 US 84404


Patients

Patient NumberTreatmentOutcomeDate
10 2017-08-10

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.